Supernus Pharmaceuticals, Inc. - Common Stock — movimiento de fondos (NASDAQ:SUPN) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas 138.4 M127.13 M116.83 M111.08 M171.95 M47.33 M 83.26 M Flujo de caja de las actividades de inversión -34.7 M-81.91 M-216.66 M268.73 M-189.87 M4.11 M -52.43 M Flujo de caja de las actividades financieras 3.56 M-130.42 M-10.48 M397.88 M12.19 M9.13 M 39.64 M Flujo de caja libre 138.4 M127.13 M116.83 M111.08 M171.95 M45.99 M 82.25 M

Noticias

Should You Buy, Sell or Hold BIIB Stock After it Rises Almost 12% YTD?

Supernus Pharmaceuticals realizará un pago de hito CVR de 33,4 millones de dólares

Supernus Pharmaceuticals, Inc. (SUPN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Supernus Pharmaceuticals, Inc. (SUPN) Q1 2026 Earnings Call Transcript

Supernus (SUPN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Supernus Pharmaceuticals (SUPN) Beats Q1 Earnings and Revenue Estimates

Bausch Health (BHC) Lags Q1 Earnings Estimates

Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs

Biogen Walloped Wall Street's First Quarter Views; Here's What Happened

BofA recorta el precio objetivo de Supernus Pharmaceuticals por los costes

Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise?

Jefferies reitera calificación de Compra para acciones de Supernus Pharmaceuticals